Amgen

Vertex Pharmaceuticals

Gilead Sciences

Regeneron Pharmaceuticals

IQVIA Hlds

Illumina

Biogen

ICON

Alnylam Pharmaceuticals

Moderna

VanEck Vectors Biotech ETF

BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.

Virtus LifeSci Biotech Clinical Trials ETF

iShares Nasdaq Biotechnology ETF

ALPS Medical Breakthroughs ETF

Biotechnology stocks and exchange traded funds have frustrated investors for over a year now, but some analysts and experts believe that this gloomy trend will end soon. Investors willing to take that bet have an array of ETFs to evaluate.

Positioning for Biotech Bounceback

Amid a rebound in growth equities last week, biotech stocks and exchange traded funds got in on the act, and that could be a positive sign for a group that's long been slumbering. For example, the ALPS Medical Breakthroughs ETF (SBIO) jumped 7.54% last week.

Biotech Stocks, ETFs Starting to Look Healthier

Biotechnology sector-related exchange traded funds gained on Monday, with Moderna Inc. (NasdaqGS: MRN) sitting among the top performers in the S&P 500, on renewed COVID-19 concerns as China implements lockdown measures to contain a new outbreak. On Monday, the VanEck Vectors Biotech ETF (BBH) rose 0.6%.

Vaccine Stocks Lift Biotech ETFs as China Enters Lockdowns

While biotechnology stocks and exchange traded funds continue frustrating market participants in the early innings of 2022, investors should not lose sight of the fact this corner of the healthcare sector offers ample exposure to innovation. Among the related ETFs, the ALPS Medical Breakthroughs ETF (SBIO) is one to consider for investors seeking a line-up full [.

SBIO Is a Good Place to Be for Biotech Innovation

SPDR S&P Biotech ETF

The macroeconomic backdrop of Fed interest rate hikes is rapidly deflating overvalued technology companies and "crypto-collectibles." We expect the technology sector to underperform value and biotech.

XBI And IBB: Sell Technology And Buy Biotech, The Only Undervalued Non-Cyclical Growth Sector

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

How Are Biotech ETFs Reacting to These Q4 Earnings Releases?

Invesco Nasdaq Biotechnology ETF

Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will return value to investors through greater share buybacks. On Tuesday, the Invesco Nasdaq Biotechnology ETF (IBBQ) was down 0.1%, the iShares Biotechnology ETF (IBB) fell 0.1%, and the VanEck Vectors Biotech ETF (BBH) was unchanged.

Biotech ETFs Muddled Despite Amgen Strength

iShares U.S. Pharmaceuticals ETF

United States Oil Fund LP

Materials Select Sector SPDR Fund

Pfizer is likely to launch Omicron vaccine in March while Moderna is working on a booster that targets the omicron variant of Covid-19.

Omicron Vaccines to Hit Market Soon? ETF Areas to Benefit

Broadly speaking, mergers and acquisitions in the healthcare sector were steady in 2021, but for many investors, there weren't enough aimed at smaller biotechnology companies. As is often the case, market observers are forecasting an uptick in biotechnology consolidation activity next year.

Biotech M&A Could Finally Perk Up in 2022

AbbVie

Novartis

Sanofi

We cover dividend stocks often at 24/7, as they provide investors with much better income streams than U.S.

Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends

Biotechnology equities are lagging the healthcare sector and the broader market this year, but with new variants of the coronavirus expected to continue popping up in 2022, it's impossible to ignore biotech assets as a potential rebound idea. That includes the VanEck Vectors Biotech ETF (BBH), which, to its credit, is trading higher this year.

Bet on BBH for Biotechnology Bounce Back

If there's an asset class that's looking forward to 2022, it's small- and mid-cap (SMID) biotechnology stocks because that group dealt with a variety of headwinds this year. However, there are more reasons for investors to monitor exchange traded funds, such as the ALPS Medical Breakthroughs ETF (SBIO), beyond “things can't get much worse” sentiment.

Smaller Biotech Stocks Ready to Perk Up

iPath Series B Bloomberg Softs Subindex Total Return ETN

iShares TIPS Bond ETF

Simplify Volt RoboCar Disruption and Tech ETF

Teucrium Wheat Fund

The emergence of the Omicron variant of Covid-19 and inflationary pressure were key highlights of the broader market in November.

BBH: Better Than IBB For Covid Exposure Including The Omicron Variant

Amplify Travel Tech ETF

Amplify Video Game Tech ETF

Pfizer

Direxion Work From Home ETF

Technology Select Sector SPDR Fund

The emergence of a new coronavirus strain, namely Omicron, has caused a massacre on Wall Street on Friday. These ETFs could gain/lose in the coming days if Omicron cases continue to rise.

ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus

How Are Biotech ETFs Reacting to These Q3 Earnings Releases?

Principal Healthcare Innovators Index ETF

First Trust NYSE Arca Biotechnology Index Fund

In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.

Can Biotech ETFs Gain From Positive Booster Update?

ProShares Ultra Nasdaq Biotechnology

iShares Genomics Immunology and Healthcare ETF

iShares Evolved U.S. Innovative Healthcare ETF

The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.

Take a Look at the Top-Performing Biotech ETFs YTD

VanEck Vectors Biotech ETF is a biotech centric ETF with passive investment approach. The fund invests in a small number of biotech companies.

BBH: This ETF Provides Robust Returns To Investors In The Biotech Sector

This year hasn't been kind to biotechnology stocks and related exchange traded funds. The headwinds faced by these assets were ratcheted up last week when the Biden administration revealed plans to pursue lower drug prices.

Biotech Stocks Have Colds, but They Can Heal

Global X Telemedicine & Digital Health ETF

Global X Education ETF

iShares S&P 500 Value ETF

iShares U.S. Technology ETF

Vanguard Mega Cap Value ETF

Vanguard Information Technology ETF

Let's take a look at some ETF areas that can be good investment options for September.

Best ETF Areas for Placing Your Bets in September

First Trust Nasdaq Bank ETF

Invesco S&P 500 Pure Growth ETF

SPDR S&P Semiconductor ETF

Let's take a look at some top-ranked ETFs that outperformed Wall Street in August.

5 Top-Ranked ETFs That Outperformed in August

The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

Biotech ETFs to Benefit From Latest Booster Update

How Are Biotech ETFs Reacting to These Q2 Earnings Releases?

iShares Select Dividend ETF

ProShares S&P 500 Dividend Aristocrats ETF

First Trust NASDAQ-100 Technology Sector Index Fund

SPDR S&P Dividend ETF

Vanguard Dividend Appreciation ETF

Let's take a look at some ETF areas that can be good investment options for August.

News for VanEck Vectors Biotech ETF ETF (BBH)